Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy

Nicole A. Carreau, Orrin Pail, Philippe Armand, Reid Merryman, Ranjana H. Advani, Michael A. Spinner, Alex Herrera, Robert Chen, Sarah Tomassetti, Radhakrishnan Ramchandren, Muhammad S. Hamid, Sarit Assouline, Raoul Santiago, Nina Wagner-Johnston, Suman Paul, Jakub Svoboda, Steven Bair, Stefan Barta, Yang Liu, Sunita NathanReem Karmali, Madelyn Burkart, Pallawi Torka, Kevin David, Catherine Wei, Frederick Lansigan, Lukas Emery, Daniel Persky, Sonali Smith, James Godfrey, Julio Chavez, Yuhe Xia, Andrea B. Troxel, Catherine Diefenbach*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences